Clinical Trial Update: Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial (NCT00094744) comparing part-time versus full-time patching for severe amblyopia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amblyopia

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Amblyopia | Phase 3 | Status: COMPLETED